Table 2.
List of anti-cancer drugs screened.
| Drug Name | FDA Approved | Drug Name | FDA Approved |
|---|---|---|---|
| Barasertib | Trichostatin | ||
| Bortezomib | yes | Cediranib | |
| Decitabine | yes | Dasatinib | yes |
| Enzastaurin | Panobinostat | ||
| Lapatinib | yes | SAHA | yes |
| MLN8237 | SNS-032 | ||
| NAC | yes | Carfilzomib | |
| Pazopanib | yes | Alvocidib | |
| Ponatinib | AUY922 | ||
| Quinacrine | yes | AZD-8931 | |
| RO4929097 | BEZ 235 | ||
| Ruxolitinib | Cabozantinib | ||
| Selumetinib | Cilengitide | ||
| SJ-172550 | Dinaciclib | ||
| Sodium butyrate | yes | Entinostat | |
| Sorafenib | yes | Fenretinide | |
| SP600125 | Fostamatinib | ||
| Temsirolimus | yes | Lenalidomide | |
| Veliparib | Nilotinib | ||
| Vismodegib | PF 562271 | ||
| Zibotentan | Retinoic acid | ||
| Crizotinib | yes | RO5045337 | |
| GANT61 | Saracatinib | ||
| BMS 754807 | SB-431542 | ||
| OSI-906 | Tamoxifen | ||
| MK-2206 | Vandetanib | ||
| Pelitinib | Vemurafenib | ||
| BIX 01294 | VER-155008 | ||
| Tozasertib | ABT 737 | ||
| Obatoclax | SJ-172550 |